Cargando…
Characteristics of genomic mutations and signaling pathway alterations in thymic epithelial tumors
BACKGROUND: To elucidate the mechanisms of thymic epithelial tumor (TET) canceration by characterizing genomic mutations and signaling pathway alterations. METHODS: Primary tumor and blood samples were collected from 21 patients diagnosed with TETs (thymoma and thymic cancer), 15 of whom were screen...
Autores principales: | Yang, Weilin, Chen, Sai, Cheng, Xinxin, Xu, Bo, Zeng, Huilan, Zou, Jianyong, Su, Chunhua, Chen, Zhenguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667121/ https://www.ncbi.nlm.nih.gov/pubmed/34988168 http://dx.doi.org/10.21037/atm-21-5182 |
Ejemplares similares
-
Relationship of possible biomarkers with malignancy of thymic tumors: a meta-analysis
por: Zeng, Huilan, et al.
Publicado: (2020) -
Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
por: Cheng, Xinxin, et al.
Publicado: (2021) -
Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration
por: Xiao, Jiefei, et al.
Publicado: (2018) -
Factors affecting improvement of neurologic status evaluated by Quantitative Myasthenia Gravis Score for patients with thymomatous myasthenia gravis after extended thymectomy
por: Haoshuai, Zhu, et al.
Publicado: (2021) -
Neurological outcomes of extended thymectomy for thymomatous myasthenia gravis: Subxiphoid vs. trans-sternal approaches
por: Zhu, Haoshuai, et al.
Publicado: (2022)